About this episode

The episode discusses China's rise in global clinical trial output and the implications for US biomedical innovation.

Theo Jaffee and Gabriel Dickinson speak with Cremieux about China’s rapid rise to the top of global clinical trial output. They discuss the regulatory reforms that accelerated China’s progress, the surge in novel drug development, and what the US would need to change to stay competitive in biomedical innovation.

More episodes of The a16z Show

• John and Patrick Collison on Stripe's Growth, Agent Commerce, and the Future of Software · April 28, 2026 · 20 min

Explore listener stats, chart rankings, contacts and more on the The a16z Show podcast page.